COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the co...

Full description

Saved in:
Bibliographic Details
Main Authors BINCH, HAYLEY MARIE, FANNING, LEV TYLER DEWEY, HURLEY, DENNIS JAMES, JOSHI, PRAMOD, CHARRIER, JEAN-DAMIEN, DURRANT, STEVEN JOHN, KAY, DAVID, PINDER, JOANNE, GROTE, MATTHEW PAUL, VIRANI, ANISA NIZARALI, YOUNG, STEPHEN CLINTON, REAPER, PHILIP MICHAEL, CLEVELAND, THOMAS, O'DONNELL, MICHAEL, STORCK, PIERRE-HENRI, KNEGTEL, RONALD MARCELLUS ALPHONSUS
Format Patent
LanguageEnglish
French
Published 17.11.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I wherein the variables are as defined herein.
AbstractList The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula I wherein the variables are as defined herein.
Author VIRANI, ANISA NIZARALI
JOSHI, PRAMOD
FANNING, LEV TYLER DEWEY
BINCH, HAYLEY MARIE
PINDER, JOANNE
CHARRIER, JEAN-DAMIEN
KAY, DAVID
O'DONNELL, MICHAEL
CLEVELAND, THOMAS
YOUNG, STEPHEN CLINTON
STORCK, PIERRE-HENRI
HURLEY, DENNIS JAMES
KNEGTEL, RONALD MARCELLUS ALPHONSUS
DURRANT, STEVEN JOHN
GROTE, MATTHEW PAUL
REAPER, PHILIP MICHAEL
Author_xml – fullname: BINCH, HAYLEY MARIE
– fullname: FANNING, LEV TYLER DEWEY
– fullname: HURLEY, DENNIS JAMES
– fullname: JOSHI, PRAMOD
– fullname: CHARRIER, JEAN-DAMIEN
– fullname: DURRANT, STEVEN JOHN
– fullname: KAY, DAVID
– fullname: PINDER, JOANNE
– fullname: GROTE, MATTHEW PAUL
– fullname: VIRANI, ANISA NIZARALI
– fullname: YOUNG, STEPHEN CLINTON
– fullname: REAPER, PHILIP MICHAEL
– fullname: CLEVELAND, THOMAS
– fullname: O'DONNELL, MICHAEL
– fullname: STORCK, PIERRE-HENRI
– fullname: KNEGTEL, RONALD MARCELLUS ALPHONSUS
BookMark eNrjYmDJy89L5WTQcfb3DfAP9XMJVggNdnUL9VFwDFbw9PPwdPIM8Q8KVvB3U3AMCVLw9vRzDHblYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo5G5pYW5mbGjobGRCgBAD6-Jn0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSES UTILES COMME INHIBITEURS DE LA KINASE ATR
ExternalDocumentID CA2798763A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2798763A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:52:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2798763A13
Notes Application Number: CA20112798763
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111117&DB=EPODOC&CC=CA&NR=2798763A1
ParticipantIDs epo_espacenet_CA2798763A1
PublicationCentury 2000
PublicationDate 20111117
PublicationDateYYYYMMDD 2011-11-17
PublicationDate_xml – month: 11
  year: 2011
  text: 20111117
  day: 17
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies VERTEX PHARMACEUTICALS INCORPORATED
RelatedCompanies_xml – name: VERTEX PHARMACEUTICALS INCORPORATED
Score 2.8305724
Snippet The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111117&DB=EPODOC&locale=&CC=CA&NR=2798763A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_SJ4fr2jXZQ5E2bdnEtqMfsrfRjxT2Moer-O97Dev0RUMIIQmXD7hcfpfcBeDByFhZZmOEJSi7BnpeqgNWYILNtaJgQ1bpjTWyHxjTVH9ZjBcdWLW2MNJP6Jd0jogcVSC_13K_3vwosRz5tnL7lK-w6P3ZS0xHKVt1HwaqOLbpzkMn5ArnJreUIDJHdNL4XrMQKB3gKZo2zOC-2Y1Ryua3RPFO4XCOxNb1GXTEugfHvP14rQdH_u6-G7M71tuewyMP_XmYBk5M0tj10ldixWQWTGf2LAmjmIQesZKIIBq3YvcCiOcmfDrAbpf7KS65tR-gdgldRP7iCkhFhVZkLKNMaPqwUlk5KVWDCibtYUd6H_p_krn-p-4GTqRqtIn0Frr1x6e4Q9la5_dyVb4BtzF5Ug
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsX5mQfpk8Vt7ZbsoUiXtrS6tqMfsrfRNh3sZQ5X8d_3Grbpi4YQQhIuH3C5_C65C8DDMGNCZAOEJSi7VD0XPZUVmGBzrShYly302hrZD4Zuqr_MBrMGLHe2MNJP6Jd0jogcVSC_V3K_Xv8osSz5tnLzlC-x6P3ZSQxLETt1HwaqWGPDnoZWyBXODW4qQWT06aj2vWYiUDrAEzatmcF-G9dGKevfEsU5gcMpEltVp9AoV21o8d3Ha2048rf33Zjdst7mDB556E_DNLBiksa2k06IGRMvcL2xl4RRTEKHmElEEI2bsX0OxLET7qrY7Xw_xTk39wPULqCJyL-8BLKgpVZkLKOs1PTuosfESPSGtGTSHravd6DzJ5mrf-ruoeUm_mQ-8YLXaziWatI60htoVh-f5S3K2Sq_kyv0DZLPfEU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+USEFUL+AS+INHIBITORS+OF+ATR+KINASE&rft.inventor=BINCH%2C+HAYLEY+MARIE&rft.inventor=FANNING%2C+LEV+TYLER+DEWEY&rft.inventor=HURLEY%2C+DENNIS+JAMES&rft.inventor=JOSHI%2C+PRAMOD&rft.inventor=CHARRIER%2C+JEAN-DAMIEN&rft.inventor=DURRANT%2C+STEVEN+JOHN&rft.inventor=KAY%2C+DAVID&rft.inventor=PINDER%2C+JOANNE&rft.inventor=GROTE%2C+MATTHEW+PAUL&rft.inventor=VIRANI%2C+ANISA+NIZARALI&rft.inventor=YOUNG%2C+STEPHEN+CLINTON&rft.inventor=REAPER%2C+PHILIP+MICHAEL&rft.inventor=CLEVELAND%2C+THOMAS&rft.inventor=O%27DONNELL%2C+MICHAEL&rft.inventor=STORCK%2C+PIERRE-HENRI&rft.inventor=KNEGTEL%2C+RONALD+MARCELLUS+ALPHONSUS&rft.date=2011-11-17&rft.externalDBID=A1&rft.externalDocID=CA2798763A1